Exploiting PI3K Pathway Inhibitor Therapy in Prostate Cancer

$276,976P50FY2007CANIH

University Of California Los Angeles, Los Angeles CA

Investigators

Charles Sawyercontact

Linked publications & trials

Paper 39669796 Paper 39589879 Paper 39503193 Paper 39484518 Paper 39426953 Paper 39402324 Paper 39294048 Paper 39228741 Paper 39155697 Paper 39096496 Paper 38867077 Paper 38746417 Paper 38585946 Paper 38580319 Paper 38536748 Paper 38494380 Paper 38270802 Paper 38244540 Paper 38177207 Paper 38026685 Paper 37973839 Paper 37963244 Paper 37775958 Paper 37548091 Paper 37399401 Paper 37192158 Paper 37179121 Paper 37084789 Paper 36905340 Paper 36759200 Paper 36608299 Paper 36028999 Paper 36007724 Paper 35971004 Paper 35869359 Paper 35694448 Paper 35534567 Paper 35075215 Paper 35040965 Paper 34774650 Paper 34675084 Paper 34671700 Paper 34378611 Paper 34170972 Paper 34052326 Paper 33962579 Paper 33908801 Paper 33762607 Paper 33711255 Paper 33602654 Paper 33537772 Paper 33441295 Paper 33427239 Paper 33402390 Paper 33392358 Paper 33386288 Paper 33277393 Paper 33199493 Paper 33197229 Paper 33037017 Paper 33035622 Paper 32694208 Paper 32690948 Paper 32647353 Paper 32562839 Paper 32544574 Paper 32505965 Paper 32380981 Paper 32311600 Paper 32194823 Paper 32086391 Paper 31932492 Paper 31871155 Paper 31825540 Paper 31718822 Paper 31439889 Paper 31390564 Paper 31287989 Paper 30992160 Paper 30962287 Paper 30877181 Paper 30820473 Paper 30701374 Paper 30427535 Paper 30374743 Paper 30334752 Paper 30301826 Paper 30287662 Paper 30243216 Paper 30232014 Paper 30124664 Paper 30087365 Paper 30045927 Paper 29993431 Paper 29985747 Paper 29985359 Paper 29891672 Paper 29874120 Paper 29686080 Paper 29663110

View original record on NIH RePORTER →